Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,727 across all filing types
Latest filing 2017-10-13 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
关于董少瑜先生辞去副总裁职务的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company's vice president due to retirement. It includes details about the board's approval and expresses gratitude for the individual's contributions. There is no financial data, no mention of a report or meeting materials, and no regulatory or legal proceedings. This fits the category of Board/Management Information, which covers announcements of changes in senior management.
2017-10-13 Chinese
关于公司董事何勤先生减持股份计划的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding a company director, Mr. He Qin, planning to reduce his shareholding in the company. It details the number of shares held, the planned reduction amount, timing, and compliance with relevant regulations. There is no financial data, earnings information, or report attached. This fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives.
2017-10-11 Chinese
关于本次限制性股票激励计划内幕信息知情人买卖公司股票情况自查报告
Regulatory Filings Classification · 95% confidence The document is a self-inspection report regarding insider trading activities related to a restricted stock incentive plan. It details the investigation of stock transactions by insiders and confirms no misuse of insider information. The document is a regulatory compliance disclosure about insider trading checks, not a financial report, earnings release, or management report. It does not contain financial statements or performance data. It is a regulatory filing related to insider trading compliance under securities regulations.
2017-09-20 Chinese
2017年第五次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the procedures, attendance, and voting results of a specific shareholders' meeting (the 2017 fifth extraordinary general meeting) of Kunming Pharmaceutical Group Co., Ltd. It details the legality and validity of the meeting's convening, attendance, and resolutions passed. This type of document is not a full annual report, earnings release, or management report, but rather a legal opinion related to a shareholders' meeting. It is not a simple announcement of voting results but a legal opinion on the meeting's conduct and resolutions. Given the nature of the document, it best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to the official results and validation of shareholder votes at a general meeting.
2017-09-20 Chinese
2017年第五次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2017 fifth extraordinary general meeting of shareholders of Kunming Pharmaceutical Group Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals related to a restricted stock incentive plan, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the voting results and decisions made by shareholders at the meeting, rather than presenting a full report or financial statements. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5,462 characters, which is sufficient to contain detailed voting results rather than a brief announcement. Therefore, the correct classification is DVA with high confidence.
2017-09-20 Chinese
监事会关于公司2016年度股权激励计划授予限制性股票解锁条件成就的审核意见
Audit Report / Information Classification · 90% confidence The document is a supervisory board's audit opinion on the achievement of conditions for unlocking restricted shares under the 2016 equity incentive plan of Kunming Pharmaceutical Corporation. It discusses compliance with laws, regulations, and performance conditions related to the equity incentive plan. The document is a formal opinion or report from the supervisory board rather than a full annual report, earnings release, or other financial report. It is not a simple announcement or certification but a detailed review related to equity incentive unlocking conditions. This fits best under Audit Report / Information (AR), as it is a standalone audit/review report related to internal compliance and conditions of a stock incentive plan. FY 2016
2017-09-12 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.